Identification of selective hepatitis delta virus ribozyme inhibitors by high-throughput screening of small molecule libraries

[1]  P. Lampertico,et al.  Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease , 2021, Gut.

[2]  F. Negro,et al.  HDV Pathogenesis: Unravelling Ariadne’s Thread , 2021, Viruses.

[3]  Yahiya Y. Syed,et al.  Bulevirtide: First Approval , 2020, Drugs.

[4]  F. Negro,et al.  Chronic hepatitis D and hepatocellular carcinoma: A systematic review and meta-analysis of observational studies. , 2020, Journal of hepatology.

[5]  Y. Ni,et al.  Recapitulation of HDV infection in a fully permissive hepatoma cell line allows efficient drug evaluation , 2019, Nature Communications.

[6]  F. Negro,et al.  A review on hepatitis D: From virology to new therapies , 2019, Journal of advanced research.

[7]  P. Meylan,et al.  A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism , 2018, PLoS pathogens.

[8]  M. Hiet,et al.  Hepatitis D virus replication is sensed by MDA5 and induces IFN-β/λ responses in hepatocytes. , 2018, Journal of hepatology.

[9]  F. Zoulim,et al.  HDV RNA replication is associated with HBV repression and interferon-stimulated genes induction in super-infected hepatocytes. , 2016, Antiviral research.

[10]  M. Roggendorf.  Perspectives for a Vaccine against Hepatitis Delta Virus , 2012, Seminars in Liver Disease.

[11]  P. André,et al.  Standardized One-Step Real-Time Reverse Transcription-PCR Assay for Universal Detection and Quantification of Hepatitis Delta Virus from Clinical Samples in the Presence of a Heterologous Internal-Control RNA , 2012, Journal of Clinical Microbiology.

[12]  Andrej Lupták,et al.  Processing and Translation Initiation of Non-long Terminal Repeat Retrotransposons by Hepatitis Delta Virus (HDV)-like Self-cleaving Ribozymes* , 2011, The Journal of Biological Chemistry.

[13]  K. Ino,et al.  Reporter gene expression at single‐cell level characterized with real‐time RT‐PCR, chemiluminescence, fluorescence, and electrochemical imaging , 2010, FEBS letters.

[14]  G. Herbein,et al.  Histone deacetylases in viral infections , 2010, Clinical Epigenetics.

[15]  M. Pelchat,et al.  The hepatitis delta virus RNA genome interacts with the human RNA polymerases I and III. , 2009, Virology.

[16]  Ralph Weissleder,et al.  Identification of inhibitors of ribozyme self-cleavage in mammalian cells via high-throughput screening of chemical libraries. , 2006, RNA.

[17]  Jinhong Chang,et al.  Susceptibility of Human Hepatitis Delta Virus RNAs to Small Interfering RNA Action , 2003, Journal of Virology.

[18]  Christian Trepo,et al.  Infection of a human hepatoma cell line by hepatitis B virus , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[19]  M. Lai,et al.  RNA-Dependent Replication and Transcription of Hepatitis Delta Virus RNA Involve Distinct Cellular RNA Polymerases , 2000, Molecular and Cellular Biology.

[20]  D. Lazinski,et al.  A host-specific function is required for ligation of a wide variety of ribozyme-processed RNAs. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Thomas D. Y. Chung,et al.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays , 1999, Journal of biomolecular screening.

[22]  A. Ferré-D’Amaré,et al.  Crystal structure of a hepatitis delta virus ribozyme , 1998, Nature.

[23]  E. De Clercq,et al.  Acyclic nucleotide analogs derived from 8-azapurines: synthesis and antiviral activity. , 1996, Journal of medicinal chemistry.

[24]  J. Taylor,et al.  Characterization of self-cleaving RNA sequences on the genome and antigenome of human hepatitis delta virus , 1988, Journal of virology.

[25]  J. Katze,et al.  Identifying inhibitors of queuine modification of tRNA in cultured cells. , 1988, Analytical biochemistry.

[26]  J. Taylor,et al.  Structure and replication of the genome of hepatitis delta virus. , 1986, Progress in clinical and biological research.

[27]  H. Robertson,et al.  A replication cycle for viroids and other small infectious RNA's. , 1984, Science.

[28]  D. Irwin,et al.  Inhibition of initiation of translation in L1210 cells by 8-azaguanine. , 1982, Biochemical pharmacology.

[29]  R. Purcell,et al.  delta Agent: association of delta antigen with hepatitis B surface antigen and RNA in serum of delta-infected chimpanzees. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[30]  C. Cobau.  Chemotherapy of Cancer: The Antimetabolite Approach , 1968 .

[31]  J COLSKY,et al.  Response of patients with leukemia to 8-azaguanine. , 1955, Blood.

[32]  Nathan J. Riccitelli,et al.  HDV family of self-cleaving ribozymes. , 2013, Progress in molecular biology and translational science.

[33]  Johnm . Taylor.  Chapter 3. Replication of the hepatitis delta virus RNA genome. , 2009, Advances in virus research.

[34]  J. Chia,et al.  Inhibition of Hepatitis Delta Virus Genomic Ribozyme Self-Cleavage by Aminoglycosides. , 1997, Journal of biomedical science.